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Abstract Research efforts during the last decade have
deciphered the basic molecular mechanisms governing
mitochondrial fusion and fission. We now know that in
mammalian cells mitochondrial fission is mediated by the
large GTPase dynamin-related protein 1 (Drp1) acting in
concert with outer mitochondrial membrane (OMM) pro-
teins such as Fis1, Mff, and Mief1. It is also generally
accepted that organelle fusion depends on the action of
three large GTPases: mitofusins (Mfn1, Mfn2) mediating
membrane fusion on the OMM level, and Opa1 which is
essential for inner mitochondrial membrane fusion. Sig-
nificantly, mutations in Drp1, Mfn2, and Opa1 have
causally been linked to neurodegenerative conditions.
Despite this knowledge, crucial questions such as to how
fission of the inner and outer mitochondrial membranes are
coordinated and how these processes are integrated into
basic physiological processes such as apoptosis and
autophagy remain to be answered in detail. In this review,
we will focus on what is currently known about the
mechanism of mitochondrial fission and explore the path-
ophysiological consequences of dysregulated organelle
fission with a special focus on neurodegenerative condi-
tions, including Alzheimer’s, Huntington’s and Parkinson’s
disease, as well as ischemic brain damage.
Introduction
Mitochondria play important roles in life and death of
eukaryotic cells, providing most of the ATP required for
metabolic cell processes via oxidative phosphorylation.
Moreover, in addition to regulating several other metabolic
pathways, such as Krebs cycle, fatty acid metabolism,
gluconeogenesis, and heme-synthesis, mitochondria also
control intracellular calcium signaling and apoptosis.
Although early high-resolution electron microscopy
images of the organelles—which were obtained by Palade
in the early 50s and which have since coined the standard
depictions for ensuing text book generations—displayed
static, bean-shaped, double-membrane mitochondrial units
[80], observations of living cells dating back to 1914 had
already revealed that mitochondria are extremely dynamic,
modulating their morphology through fusion and fission
processes that create highly interconnected tubular net-
works as well as punctiform solitary organelles [55]. These
continuous changes in mitochondrial morphology, driven
by antagonistic, normally balanced fusion and fission pro-
cesses are controlled by a group of evolutionary-conserved
large GTPases that share structural homology with proto-
typical dynamins [96]. Dynamins, ranging in size between
70 and 100 kDa, are mechanochemical enzymes that—
through GTP hydrolysis-driven assembly into multimeric
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spirals around the collars of invaginating vesicles—are
mainly involved in the scission of nascent endo- and exo-
cytic vesicles [53, 63, 96].
Mitochondrial fusion
In mammals, the dynamin-like GTPases mitofusin 1 and 2
(Mfn1, Mfn2) regulate OMM fusion, whereas the integral
IMM protein OPA1—in addition to mediating mitochon-
drial fusion in concert with Mfn1—mediates apoptotic
processes by regulating mitochondrial cristae maintenance
and cytochrome c release. Whereas in the most experi-
mental paradigms a fused mitochondrial phenotype seems
to protect cells from programmed cell death, forced acti-
vation of organelle fission favors apoptosis by facilitating
the release of cytochrome c from the mitochondria with the
subsequent activation of effector caspases.
Both mitofusins, Mfn1 and Mfn2, are integrated into
the OMM via a bipartite transmembrane domain, with
their C- and N-termini including the GTPase domain
facing the cytosol. Via formation of homo- as well as
heterodimers, Mfns are thought to mediate the initial step
of organelle tethering. Whereas Mfn1 exhibits higher
GTPase and organelle fusion activity, Mfn2 features
higher substrate affinity toward GTP [44]. In addition,
Mfn2, but not Mfn1, is expressed on endoplasmic retic-
ulum (ER) membranes and is thus thought to be also
important for ER–mitochondria interactions including
calcium homeostasis [25].
Interestingly, OPA1 germline mutations cause autoso-
mal-dominant optic atrophy [1, 27], whereas Mfn2
germline mutations are causally linked to an axonal var-
iant of Charcot-Marie-Tooth disease (CMT 2A) [122]. Of
note, genetic ablation of Mfn2 in spinal cord motor neu-
rons leads to their degeneration resulting in subsequent
hindlimb paralysis [28]. In addition, neurodegeneration is
also prominent in mice with cerebellar or Purkinje neu-
ron-specific Mfn2 deletions [16]. Last but not least, mice
in which Mfn1 and Mfn2 have been co-deleted specifi-
cally in skeletal muscle develop a mitochondrial
myopathy-like phenotype which recapitulates the typical
histological findings of SDH-hyperreactive/COX-negative
muscle fibres and subsarcolemmal mitochondrial accu-
mulations, accompanied by a pronounced depletion of
mtDNA [17].
Mitochondrial fission
Dynamin-related protein 1 (Drp1) displays a high degree of
evolutionary conservation and is the only known large
GTPase actively mediating mitochondrial fission. In
humans, Drp1 is highly expressed in tissues with particular
energy demands, such as brain and muscle, whereas
moderate-to-low expression levels are found in liver, lung,
placenta, kidney, and pancreas [96].
The molecular structure of Drp1 largely corresponds to
that of other proteins of the dynamin superfamily, except
for the lack of the C-terminal proline-rich domain present
in most members of the superfamily and a lacking pleck-
strin homology domain (PH) which mediates protein-
membrane interactions in dynamins [96] (Fig. 1). The
recently resolved crystal structure of dynamin shows three
protein–protein interfaces that allow the formation of
multimers. Detailed analysis of interface 2 reveals a con-
served amino-acid pattern that is unique to Drp1 and
probably responsible for its dimerization [33]. On the
cellular level, almost the entire Drp1 dimer pool is cyto-
solic with only about 3% of the total protein content
residing at the mitochondrial surface. In order to induce
organelle fission, cytosolic Drp1 requires activation and
subsequent translocation to the mitochondrial outer mem-
brane. Here, Drp1 dimers form ring-like multimeric
structures on prospective OMM fission sites through
a self-assembling process [43], followed by GTP hydro-
lysis-driven conformational changes that—via ring
constriction—lead to membrane severing and subsequent
organelle division [53, 63] (Fig. 1c). Accordingly, inte-
gration of mutated Drp1 molecules (e.g., of the K38A
mutation with incapacitated GTP hydrolysis) into the ring-
like Drp1 multimers inhibits their constriction through
dominant-negative effects, resulting in blocked organelle
fission [96] (Fig. 2). Recently, cryo-EM studies of Dnm1,
the yeast orthologues of Drp1, provided new insights into
its contractile mechanochemical properties. The magnitude
of Drp1 constriction was found to be substantially larger
than that of dynamin. A derived model postulates that Drp1
forms multimeric constrictive rings that engage in only
limited interaction with the underlying lipid bilayer leaving
a 3- to 4-nm pitch, indicating that Drp1 membrane inter-
actions may involve adaptor proteins to bridge that gap
[63].
The OMM-bound mitochondrial fission factor (Mff) has
recently been identified as such an adaptor protein for Drp1
[79] (Fig. 1a). In addition, OMM-bound mitochondrial
elongation factor 1 (Mief1) facilitates mitochondrial Drp1
translocation [121]. Curiously, by blocking GTP binding at
the GTPase domain of Drp1, Mief1 inhibits the confor-
mational change of Drp1 multimers required for membrane
fission [121] (Fig. 1d). According to a recently proposed
model, expression of mammalian Fis1—another integral
OMM protein [48]—is able to partially reverse an elon-
gated mitochondrial phenotype by sequestering Mief1 via
unblocking Drp1 GTP hydrolysis, culminating in organelle
fission [121] (Fig. 1e).
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Interestingly, a very recent report also indicates that
interorganellar contact sites between mitochondria and
adjacent endoplasmic reticulum membranes are important
for the mitochondrial division process by constricting
mitochondria at prospective fission sites, prior to the
recruitment of any of the fission-mediating proteins dis-
cussed above [36].
Posttranslational Drp1 modifications
Changes in mitochondrial shape are tightly coupled to
essential organellar and cellular functions, as exemplified
during mitosis, when the balance between fusion and fis-
sion temporarily shifts toward fission to enable equal
mitochondrial distribution to daughter cells [100]. In order
Fig. 1 Molecular regulation of Drp1-mediated mitochondrial fission.
a Activation of Drp1 by, e.g., calcineurin-mediated dephosphoryla-
tion targets the protein to mitochondria where it is thought to bind the
adaptor protein Mff. b Additional posttranslational Drp1 modifica-
tions such as ubiquitination and sumoylation stabilize Drp1 on the
OMM. c Following oligomerization, Drp1 assembles into constrictive
ring-like multimers that, upon GTP hydrolysis, mediate membrane
constriction. d Binding of Mief1 to Drp1 on the OMM inhibits GTP
hydrolysis and subsequent membrane constriction. e The OMM
protein Fis1 likely exerts its pro-fission activity by sequestering
Mief1, thereby inhibiting Drp1–Mief1 interactions
Fig. 2 Drp1 structure and posttranslational modifications. Drp1 is
composed of a N-terminal GTPase domain, a middle domain and a
C-terminal GTPase effector domain (GED), the latter—through
impacting GTP hydrolysis—influencing Drp1 oligomerization. The
K38A mutation alters catalytic core residues within the GTPase
domain; however, K38A mutant Drp1 can still oligomerize with
wildtype Drp1, thus acting as a dominant-negative mutation. The E3-
ligases March5 and parkin can ubiquitinate Drp1 at currently
unknown sites. March 5-mediated ubiquitination stabilizes the
mitochondrial Drp1 pool while parkin-mediated ubiquitination targets
Drp1 for proteasomal degradation. Phosphorylation of Drp1 can exert
either activating or inactivating effects. Drp1 phosphorylation at S616
by the CDK1/CyclinB complex triggers Drp1-mediated mitochondrial
fission during mitosis. In contrast, PKA-mediated phosphorylation at
S637 inhibits mitochondrial Drp1 translocation; this effect can be
antagonized by the phosphatase calcineurin. Sumoylation of Drp1 can
occur at multiple sites between the middle and GED domains, and is
mediated by various ubiquitin ligases such as Sumo1, Ubc9, and
MAPL. Sumoylation of Drp1 stabilizes its association with mito-
chondria. Finally, mitochondrial fission in the context of Alzheimer’s
disease involves Ab-mediated S-nitrosylation of Drp1 at position
C644
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to allow for rapid adaptation to continuously changing
cellular needs, extensive post-translational modifications
such as phosphorylation, sumoylation and ubiquitination
are in place, which, by regulating the activity of mito-
chondrial morphogenic proteins, directly impinge on
organelle morphology (Fig. 2). When activated by
increased cAMP levels, protein kinase A (PKA) phos-
phorylates Drp1 at residue Ser637, thereby inhibiting its
GTPase activity as well as intermolecular Drp1 interactions
resulting in elongated mitochondria [14, 22]. This mecha-
nism is being exploited during starvation where
mitochondrial elongation resulting from PKA-mediated
Drp1 phosphorylation can protect starving cells from
autophagy [38]. PKA-mediated Drp1 phosphorylation at
Ser 637 is counteracted by calcineurin, whose activation
leads to organelle fragmentation by boosting Drp1 trans-
location to mitochondria [14, 112]. As calcineurin
activation occurs in response to increased cytosolic
calcium levels, this mechanism could be activated in Ca2?-
mediated neuronal injury, e.g., during ischemia or excito-
toxicity. Of note, increased calcineurin activity and
subsequent mitochondria fission were recently shown to
participate in neuronal toxicity in a Huntington disease
mouse model [21].
During mitosis, phosphorylation at Drp1 position S616
also activates Drp1, triggering mitochondrial fission to
enable even mitochondrial distribution to cellular progeny.
This phosphorylation event is mediated by the Cdk1/
CyclinB complex under the control of the small Ras-like
GTPase RALA and its effector RALBP1 [51, 100].
Although cell cycle-coupled events are obviously less
significant in postmitotic cells, increased levels of Drp1
S616 phosphorylation were recently found in Alzheimer’s
disease-affected brains [113]. In postmitotic neurons, the
S616 site can alternatively be phosphorylated by protein
kinase C d (PKCd) in vitro as well as in vivo, as demon-
strated in a rat model where hypertensive encephalopathy
was shown to be associated with mitochondrial fission,
accompanied by increased Drp1/PKCd interactions on
mitochondria [86].
In addition to the various phosphorylating modifications
discussed above, Drp1 is subject to ubiquitination. To date,
MARCH5 as well as parkin have been shown to act as E3
ligases with substrate specificity to Drp1. However,
MARCH5-mediated ubiquitination stabilizes Drp1 on
mitochondria [50, 83], while parkin-mediated ubiquitina-
tion promotes the proteasomal degradation of Drp1 [111].
Sumoylation, a related posttranslational Drp1 modifica-
tion, is mediated by the small ubiquitin modifier (Sumo)
which stabilizes Drp1 levels, thereby supporting mito-
chondrial fragmentation. Sumoylation of Drp1 is performed
by Sumo1, Ubc9 and MAPL [9, 32, 41, 115, 123], while
desumoylation is mediated by SenP5 [123, 124]. In the
future, it will undoubtedly be interesting to test the question,
in how far the impaired turnover of specific mitochondrial
morphogenesis proteins is pathogenically important in the
context of neurodegeneration, and whether modulating their
expression levels may potentially ameliorate the clinical
course of these usually relentlessly progressing diseases.
Drp1 in neuronal morphogenesis, homeostasis,
and neurodegeneration
It is a well-known fact that most neurodegenerative dis-
eases occur sporadically, with age being the most
significant risk factor. Remarkably, more than one-third out
of 106 genes that have so far been linked to neurodegen-
erative diseases, are key regulators of mitochondrial
function [92]. Mutations in two of the mitochondria shap-
ing proteins have been causally linked to familial
neurodegenerative diseases. Whereas autosomal-dominant
Mfn2 mutations pathogenically underlie Charcot-Marie-
Tooth Disease type 2A (CMT2A) [122], a peripheral
axonal neuropathy, Opa1 mutations lead to autosomal-
dominant optic atrophy (ADOA) [1, 27]. In addition, the
mitochondrial fission protein Drp1 can sporadically be
affected by mutations in humans, as exemplified by the
report of a lethal syndromic birth defect attributable to a
heterozygous Drp1 mutation [117]. In this case, a newborn
presented clinically with truncal hypotonia and insufficient
to absent optic and motor reflexes accompanied by per-
sistent lactic acidemia; the infant died at day 37 after birth.
Workup of that case revealed marked microcephaly,
abnormal brain development with abnormal gyral patterns
as well as optic atrophy. This severe developmental phe-
notype hinted—for the first time—at a crucial role of Drp1
for brain development. Given the early embryonic lethality
of mice genetically ablated for the mitochondrial fusion
proteins Mfn1, Mfn2 [15] as well as of constitutive Drp1
knockout mice (see below), it seems plausible that Drp1
mutations may cause early embryonic mortality in humans
as well, with a high chance of going undetected in the
clinical practice. The importance of Drp1 for the neuronal
development has recently been confirmed beyond doubt by
two murine models of genetic Drp1 ablation, each resulting
in early embryonic lethality (e11.5). Drp1-ablated embryos
display pronounced defects in the organ development
affecting liver, heart and the neural tube, and lack the
trophoblast giant cell layer [45, 108]. Both groups were
further able to generate neuronal-specific Drp1 knockout
mice using different approaches. In both models, murine
embryos seem to develop normally, but die at postnatal day
0. Employing the engrailed1 (EN1) promoter, Wakabay-
ashi and coworkers [108] ablated Drp1 specifically in the
midbrain and the cerebellum, which appeared smaller,
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devoid of lobar structures, and showed decreased numbers
of Purkinje neurons containing fewer mitochondria.
Ishihara et al. [45] ablated Drp1 pan-neurally using the
nestin promoter, which normally gets activated at around
day e9.5. At e18.5, a reduction of forebrain size with white
matter hypoplasia and periventricular leukomalacia was
observed, accompanied by markedly enlarged subdural and
ventricular spaces. In addition, hypoplasia of brain stem
and cerebellum was noted. Further analyses revealed a
significantly increased number of TUNEL-positive neurons
in deep cortical layers. Interestingly, Drp1 is highly
expressed in layer V of the adult mouse neocortex [6],
roughly correlating with the many TUNEL-positive cells at
the cortex-white matter junction of Drp1-ablated mice [45].
On the cellular level, it is interesting to note that neurons
express mitochondria-shaping proteins at particularly high
levels, which very likely reflects the peculiar morphologi-
cal and biochemical characteristics of this highly
ATP-dependent cell type. In vitro, expression of the
dominant-negative Drp1 mutant K38A in rat hippocampal
neurons reduces the number of dendritic spines, under-
scoring again the importance of Drp1 for neuronal
morphogenesis [56] (Fig. 3c). In line with these observa-
tions, mixed neuronal cultures derived from nestin-Cre
Drp1 knockout mice also feature decreased synapse
formation and exhibit a decreased number of neurites [45]
(Fig. 3c), whereas in postnatal cortical mouse neurons
Drp1 downregulation or expression of a dominant-negative
Drp1 mutant causes cell death [104]. Interestingly, also
activity-stimulated formation of excitatory synapses is
blocked by expression of dominant-negative Drp1 mutants,
whereas synapse formation is potentiated by the expression
of wildtype Drp1 [56].
Finally, it should be noted here that synapses in Dro-
sophila Drp1 mutants are largely devoid of mitochondria,
apparently without synapse function impairments. How-
ever, significant defects in the ATP-dependent recruitment
of reserve pool vesicles are found, indicating that mito-
chondria present in the synaptic compartment are required
to satisfy sustained local energy needs [106].
Mitochondria are abundant at synapses [89] as well as
within the active growth cones of developing neurons [70].
As will be discussed later, mitochondrial trafficking is an
energy-dependent process that requires appropriate struc-
ture and function of the organelles. Mitochondria in
neurons lacking functional Drp1 tend to aggregate in the
perikarya [45, 56, 104] (Fig. 3c). In the developmental
models, the neuronal demise that follows the inactivation
of Drp1 seems to be largely dependent on impaired synapse
formation and neurite outgrowth, both of which can prob-
ably, at least in part, be attributed to mitochondrial
trafficking problems. Curiously, the mitochondrial pheno-
types that can be observed in neurons with reduced Drp1
activity are not uniform, ranging between an elongated
organelle network that branches out into neurites (Fig. 3b)
to aggregated perinuclear mitochondrial accumulations
(Fig. 3c). This phenotypic variability seems to depend on
specific experimental conditions such as, e.g., the mode of
Fig. 3 Mitochondrial phenotypes in fission-incompetent neurons.
a Different mitochondrial phenotypes have been reported for Drp1-
deficient neurons. Wildtype mitochondrial morphology is character-
ized by evenly distributed organelles in the axonal, neuritic and
perikaryon compartments. b Following functional Drp1 inactivation
in neurons an elongated mitochondrial morphology that branches
out into the neurites can be observed; under these conditions,
mitochondria do not fragment during apoptosis and are protected
from cell death [4, 18, 21, 24, 46, 63, 101, 119, 120]. c Others found
impaired mitochondrial trafficking with elongated organelles aggre-
gating within the perikaryon, accompanied by decreased numbers of
neurites and synapses [45, 56, 104]. The relative contribution of
potential mtDNA losses as well as ROS to neuronal degeneration has
not been clarified in detail
Acta Neuropathol (2012) 123:189–203 193
123
functional Drp1 inactivation, time after transfection or
lentiviral infection [4, 18, 21, 24, 40, 46, 66, 101, 119,
120]. It is thus tempting to speculate that the elongated
mitochondrial morphology branching into neurites and
dendrites (Fig. 3b) represents a transitory state that can be
observed shortly after Drp1 functional inactivation,
whereas the perinuclear mitochondrial clustering associ-
ated with degeneration of neuronal processes (Fig. 3c) may
result from long-term Drp1 deprivation.
Drp1 in Alzheimer’s disease
Clinically characterized by progressive decline of cognitive
functions and memory, Alzheimer’s disease (AD) is a late-
onset neurodegenerative disease that leads to the most
common form of dementia. Traditional pathological hall-
mark features of AD comprise the formation of
neurofibrillar tangles composed of hyperphosphorylated
tau protein as well as senile plaques formed by aggregated
amyloidogenic A-beta-peptides derived from proteolytic
cleavage of amyloid precursor protein (APP). During the
past few years evidence has been emerging indicating that
dysregulated mitochondrial structure and morphology may
represent an important component in the complex patho-
genesis of AD.
Neurons that are either overexpressing APP or exposed to
toxic A-beta peptides display abnormal levels of mitochon-
dria shaping proteins in association with a perinuclearly
aggregated mitochondrial phenotype [4, 60, 113, 114]. These
findings are paralleled by studies of AD patient brains
reporting abnormal expression levels of mitochondrial
morphogenic proteins [60, 113]. Of note, specific abnormal
interactions between Drp1 and A-beta have recently been
identified in AD brains [60]. In addition, Tau hyperphosph-
orylation as well as neurofibrillary tangle formation seem to
be linked to an abnormal mitochondrial distribution in neu-
rons [52]. Whether this abnormality exclusively results from
disruption of microtubule-based organelle transport or
whether dysbalanced mitochondrial fission and fusion pro-
cesses contribute to this phenotype, remains unclear at
present. Finally, specific post-translational Drp1 modifica-
tions have recently been implicated with AD. For example,
increased levels of Drp1 phosphorylation at position S616
are found in AD brains [113]. Moreover, Drp1 can undergo
S-nitrosylation at residue C644, promoting mitochondrial
fission [19, 73, 113].
Drp1 in Huntington’s Chorea
A progressive monogenic neurodegenerative disorder,
Huntington’s disease (HD) is inherited in an autosomal-
dominant pattern. It is clinically characterized by invol-
untary movements such as chorea and dystonia,
accompanied by psychiatric disturbances and cognitive
decline leading to dementia. Albeit most of the patients
experience initial symptoms in their midlife, HD also
includes juvenile onset forms. On the molecular level, an
intragenic CAG-triplett expansion within the huntingtin
(Htt) gene on chromosome 4 results in an abnormal stretch
of polyglutamine residues, determining age of onset and
disease severity. Histopathological correlates include
progressive neuronal loss affecting in particular striatal
GABAergic spiny neurons, accompanied by atrophy and
gliosis in basal ganglia, cortex, and hippocampus. With
several theories existing on the neurotoxicity of mutant
Htt aggregates, the exact pathobiology of HD remains to
be determined. Transcriptional dysregulation, defective
intracellular trafficking, and abnormal mitochondrial bio-
energetics and dynamics are all currently being discussed
as pathogenic factors [109].
HD-like phenotypes can easily be recapitulated in
transgenic mice expressing full-length mutant Htt or a
N-terminal Htt fragment. Neuronal losses and other
pathological features of HD as well as the occurrence of
clinical symptoms following pharmacologic inhibition of
electron transport chain (ETC) complex II [8] lend strong
support for a significant mitochondrial component in HD
pathogenesis.
Recent studies in HD patient lymphoblasts as well as in
primary striatal neurons isolated from HD mouse models
revealed a fragmented mitochondrial morphology in con-
cert with an increased susceptibility to apoptotic stimuli.
Additionally, increased calcineurin activity paralleled
by dephosphorylation and association of Drp1 with mito-
chondria has been reported [21]. Intriguingly, this
phenotype is accompanied by changes in mitochondrial
ultrastructure. Of note, the effects of mutant Htt on mito-
chondrial fragmentation can be rescued either by the
expression of Opa1, the dominant-negative Drp1 mutation
K38A, or a dominant-negative calcineurin mutant. The fact
that, unlike Opa1, expression of the mitochondrial fusion
protein Mfn1 is unable to counteract the increased apop-
tosis susceptibility of mutant Htt cells emphasizes the
importance of Opa1-dependent cristae maintenance, which
provides protection from inappropriate cytochrome
c release and ensuing apoptotic cell death [21].
In addition to increased mitochondrial fragmentation
and neuronal cell death susceptibility, impaired mito-
chondrial trafficking has also been demonstrated in mutant
Htt cell lines. Mutant huntingtin binds to mitochondria,
where it assembles into large oligomers at prospective
fission sites, similar to Drp1 complexes. Apparently, the
co-localization of Drp1 and mutant Htt at mitochondrial
fission sites is based on specific Drp1/Htt interactions, that
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are much weaker in the case of wildtype in comparison to
mutated Htt [97].
In human HD brain, the occurrence of mutant Htt
aggregates correlates well with the expression of mito-
chondrial fission-mediating proteins. In particular, in
striatal and cortical specimens from HD patients, mito-
chondrial fission genes Drp1 and Fis1 are expressed at
higher mRNA and protein levels, whereas Opa1, Mfn1 and
Mfn2 fusion proteins are decreased. Finally, an increased
expression of mitochondrially encoded ETC genes as well
as significant oxidative DNA damage have been demon-
strated in human HD brains, once again reflecting the
pathogenically important relationship between mutant HTT
and mitochondrial dysfunction in HD [95].
Drp1 in Parkinson’s disease
Parkinson’s disease (PD) is the second most common
neurodegenerative disease affecting roughly 1% of the
population aged 65 years or above [107]. Roughly 10% of
all cases are associated with mutations in different PARK
gene loci, the remaining cases being sporadic with age
being the major risk factor. PD pathology is characterized
by the loss of dopaminergic neurons in the substantia nigra
pars compacta and the formation of intraneuronal inclu-
sions known as Lewy bodies (LB) [30, 31]. On the
molecular level, PD pathogenesis has long been regarded
as being primarily caused by mitochondrial dysfunction,
and, more recently, also by impaired protein turnover
causing accumulation of toxic protein aggregates. Apart
from LB formation, levels of core components of the
ubiquitin–proteasome system are decreased [62] paralleled
by increased numbers of autophagic vacuoles in PD brains
[2]. Further, it has long been known that exposure to ETC
complex I inhibiting toxins such as 1-methyl-4-phenylp-
iridinium (MPP?), rotenone or paraquat can rapidly induce
PD-like symptoms in humans and laboratory animals [54,
65]. In addition, complex I deficiency [91] and elevated
ROS levels [61] are frequently observed in PD patients.
Moreover, two of the PARK genes, parkin and Pink1, play
pivotal roles in the removal of damaged mitochondrial
organelles via mitophagy [75, 76], and work published
earlier this year has identified Drp1 as one of the targets of
the E3 ubiquitin ligase, parkin [111].
Interestingly, expression of PKA or of the Drp1 S637D
phosphomimetic mutation (this S637 phosphorylation is
mediated by PKA) can revert the mitochondrial pro-
fission phenotype of Pink1-deficient cells [23]. In addi-
tion, Pink1-deficient cells display increased calcineurin
activity; accordingly, their pro-fission phenotype can be
reverted by treatment with the calcineurin inhibitor FK506
[90].
The fascinating interplay of parkin, Pink1, and Drp1,
which orchestrates mitophagy will be discussed in greater
detail by Pilsl and Winklhofer (also this issue). Suffice it to
note here that alpha-synuclein, another PARK gene and
major LB component [98], associates with mitochondria
and induces Drp1-independent mitochondrial fragmenta-
tion [72]. It will be interesting to test in how far recently
reported physiological tetrameric alpha-synuclein [5] is
capable of modulating mitochondrial dynamics. In sum-
mary, mitochondrial dysfunction significantly contributes
to PD pathology. To what extent dysregulated mitochon-
dria morphogenesis and turnover contribute to the
pathogenesis of sporadic PD remains to be elucidated.
Drp1 in ischemic brain damage and excitotoxicity
Surrounding the necrotic ischemic core where neurons
perish by necrosis as an immediate consequence of lacking
nutrients, the penumbra receives reduced nutrient supply
and remains metabolically active. Cells within the pen-
umbra are susceptible to apoptotic cell death, which occurs
primarily as a consequence of excitatory amino acids and
proteolytic enzymes released from the necrotic core region.
As the penumbra can make up more than half of the total
infarction size and apoptotic pathways can be targeted
increasingly successfully [11], understanding the patho-
physiology of ischemic brain damage is imperative for the
successful development of neuroprotective strategies tar-
geting such socio-economically important conditions as
ischemic stroke [11].
In murine models of cerebral ischemia mitochondria
within the penumbra have been shown to fragment [4]. As
Drp1-mediated mitochondrial fragmentation is commonly
observed early during apoptosis with its inhibition delaying
programmed cell death in most experimental scenarios,
chemical inhibition of Drp1 using small molecule inhibi-
tors has recently emerged as a promising therapeutic
strategy. This is exemplified by mdivi-1, a Drp1-inhibiting
compound [12] which significantly increases neuronal
survival in a murine retinal ganglion ischemia model [82].
Remarkably, mdivi-1 is also effective in reducing infarct
sizes in renal [10] and cardiac ischemia [77]. In this
context, it is interesting to note that transgenic mice
overexpressing miR-499 show reduced myocardial infarc-
tion sizes when subjected to cardiac ischemia [112].
miR-499 is a micro RNA targeting calcineurin (which
under normal conditions favors mitochondrial fragmenta-
tion via Drp1 dephosphorylation [14]).
In addition to increasing susceptibility toward apoptosis,
the pronounced lack of nutrients within the penumbra may
be sufficient to trigger adaptive autophagic responses. The
observation that autophagy seems to decline with age [57]
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might represent one underlying biochemical correlate for
the relatively poor neurologic outcome of older ischemic
stroke patients. Mounting evidence suggests that, in addi-
tion to fostering the elimination of potentially toxic protein
aggregates, autophagy can serve to maintain high ATP
concentrations. Autophagy may thus be fundamentally
important under conditions of limited nutrient supply as
reflected by the observation that during starvation—one of
the traditional autophagy triggers—mitochondria become
hyperfused [38]. Such hyperfused states facilitate the for-
mation of ATP synthase dimers, which are more efficient in
producing ATP [99]. As fragmented mitochondria are less
potent ATP producers, improving energetic levels within
the penumbra by pharmacologically inhibiting mitochon-
drial fission may represent a neuroprotective strategy
remaining to be tested by future experimentation.
In addition to the limited nutrient supply, neurons within
in the cerebral penumbra are exposed to extreme Ca2?-
mediated excitotoxic stress. Energy depletion inhibits
membrane potential maintenance with the subsequent
depolarization triggering the release of synaptic vesicles
that contain excitatory amino acids. Moreover, excitotoxic
stress induced by activation of ionotropic NMDA receptors
on presynaptic membranes allows for Ca2? influx, thereby
dramatically elevating intracellular Ca2? levels which—
when exceeding the uptake capacities of the endoplasmic
reticulum—may result in neuronal cell death. Sharp rises in
mitochondrial Ca2? can activate Drp1 through calcineurin-
mediated dephosphorylation, and trigger mitochondrial
permeability transition with subsequent activation of the
mitochondrial gateway to apoptosis. In addition, Ca2?
influx into neurons is known to activate calpains (a class of
calcium-dependent cysteine proteases). Calpains have been
shown to stimulate neuron-specific cyclin-dependent
kinase 5 (Cdk5) forcing cell cycle re-entry of postmitotic
neurons and promoting neuronal death [11, 59]. Moreover,
glutamate stimulation of neuronal NMDA receptors leads
to reduced mitochondrial motility and fragmentation of the
organelles, finally culminating in cell death [47, 87, 119].
Of note, death induced by NMDA receptor-stimulated
Ca2? influx can be blocked by overexpression of Opa1 [47]
and, in vivo, by overexpression of the endogenous calpain
inhibitor, calpastatin [42].
Taken together, the currently available evidence sug-
gests that Drp1-mediated mitochondrial fission contributes
to neuronal cell loss under ischemic and excitotoxic con-
ditions. Pharmacological inhibition of the fission
machinery, e.g., by the small molecule Drp1 inhibitor
mdivi-1, appears to represent a plausible approach that
should extensively be tested for its potential as neuropro-
tective therapeutic strategy. Of note, the protective effects
of chemical Drp1 inhibition under ischemic conditions
may—at least in part—be attributed to metabolic effects
associated with mitochondrial elongation rather than inhi-
bition of apoptosis per se.
Drp1 and metabolism
Although there is no robust experimental data available to
verify a link between Drp1 activity (or organelle mor-
phology) and mitochondrial respiration in neurons, recent
evidence indicates that hyperfused mitochondria are more
efficient in ATP production [38, 67, 102]. This hyperfused
state is observed under stress conditions such as exposure
to toxins (UV light, cycloheximide, actinomycin D) [102],
during starvation [38], or during the energy-demanding G1
to S phase transition of mitosis [67]. Of note, the starva-
tion-induced hyperfused state depends on PKA-mediated
phosphorylation of Drp1 at Ser637 that inactivates Drp1
fission activity. In addition, ATP synthase dimer formation
is increased [38] resulting in more efficient ATP generation
under low mitochondrial membrane potential conditions
[99]. In how far ATP-Synthase dimer formation leading to
increased mitochondrial ATP production by hyperfused
mitochondria represents a general protective mechanism in
stressed cells remains to be elucidated. Long-term genetic
Drp1 ablation, on the other hand, decreases respiratory
activity [81, 84, 103] or has no to negligible effects [45].
Perhaps, genetic Drp1 deletion induces additional compen-
satory mechanisms beyond just tipping the balance toward
mitochondrial fusion. Nevertheless, forced induction of
hyperfusion through direct inhibition of mitochondrial
fission may potentially represent a neuroprotective strategy
for acute neuronal stress conditions such as ischemia,
deserving further exploration.
Drp1 and impairment of mitochondrial quality control
As mitochondrial quality control mechanisms are reviewed
elsewhere in this issue, we will focus our discussion here to
the question of how Drp1 relates to mitochondrial quality
surveillance.
Three mitochondrial components require continuous
recycling: mtDNA, proteins, and lipids. Single mitochon-
drial organelles carry several mtDNA copies, ensuring that
intact mtDNA molecules can compensate for damaged
(i.e., mutated) ones. It is thus believed that—via fusion of
the organelles—mitochondria constantly exchange their
mtDNA content within single cells. Proof of functionally
important mtDNA exchange was first provided more than a
decade ago through a very elegant approach [78]: through
hybridizing two cell lines each carrying one specific
mtDNA mutation associated with respiratory deficiency,
normal respiration rates could be restored [78]. In addition,
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experiments with mice carrying mtDNA mutations proved
that, in fact, a population of mitochondria within one cell
shares a common pool of mtDNA [71]. The process of
mitochondrial complementation is highly dependent on
organelle fusion as demonstrated in a murine muscle-spe-
cific Mfn2 knockout model, where mtDNA mutations
accumulate at similar rates as in mice expressing a proof-
reading defective mitochondrial DNA polymerase mutant
[16]. Evidence suggesting a significant role for Drp1-
mediated mitochondrial fission in mtDNA maintenance is
scarce; in HeLa cells, Drp1 downregulation leads to loss of
mtDNA as determined by immunofluorescence microscopy
using anti-DNA antibodies [84].
The mechanisms of mitochondrial protein and lipid
turnover are still poorly understood at present. Through a
specialized autophagic process termed mitophagy, double-
membrane structures are formed which enclose entire
mitochondrial organelles and which subsequently fuse with
lysosomes. It has been shown that the pro-fission OMM
protein Fis1 is essential for mitochondrial trafficking to
autophagosomes [39]. Of note, expression of mutant Drp1
is able to block mitochondria removal [3]. More recently, it
has been shown that Drp1-mediated fission can give rise to
depolarized single mitochondrial units that subsequently
undergo mitophagy [103]. In line with this fundamental
observation, Drp1 ablation leads to an accumulation of
oxidized proteins in mitochondria [84, 103]. Finally, as
mentioned earlier, the Pink1/parkin pathway that also
involves direct interactions with Drp1, contributes signifi-
cantly to mitochondrial quality control [111]. As, at the
moment, no assays are available to directly quantify
mitochondrial turnover and mitophagy, the direct contri-
butions of Pink1/parkin and Drp1 to mitochondria quality
control via organelle turnover/mitophagy still remain to be
clarified in detail.
Drp1 and aberrant mitochondrial trafficking
Neurons, the longest human cells which can exceed lengths
of one meter, are especially dependent on a proper mito-
chondrial distribution. Distinct long- and short-distance
mitochondrial transport mechanisms exist in order to sat-
isfy the particularly high local energy demands at synapses
and nodes of Ranvier. Significantly, aberrant mitochondrial
trafficking is likely the primary cause underlying the CNS
developmental defects including perturbed synapse for-
mation in Drp1 knockout mice. In neurons, microtubule
tracks are used as long-distance transport rails to cargo
membrane vesicles and cellular organelles including
mitochondria. Axonal transport of mitochondria is bidi-
rectional and thought to be coordinated with neuronal
outgrowth [70]. Whereas anterograde (i.e., synapse-bound)
cargo movement is mediated by kinesins, dynein/dynactin
act promiscuously in retrograde (i.e., perikaryon-bound)
organelle transport.
The protein couple Miro/Milton, acting in concert with
kinesins, is responsible for anterograde mitochondrial
trafficking, with Ca2? binding Miro being anchored to the
OMM. In a calcium-unbound state, Miro binds to Milton,
which in turn can bind to kinesin motorproteins. Upon
exposure to high calcium levels, as they occur, e.g., within
the pre- or postsynaptic compartments, the molecular Miro/
Milton interaction gets disrupted, releasing mitochondria
[58]. The only mitochondria-shaping protein so far directly
implicated in this process is Mfn2, which interacts with the
Miro/Milton complex.
The multimeric dynein complex comprising dynactin
and its subunit p50/dynamitin is responsible for retrograde
mitochondrial transport. Interestingly, mitochondrial Drp1
foci colocalize with microtubules [105, 118]. Dysruption of
the dynein complex or expression of the Drp1 K38A
mutant interrupts Drp1/microtubule colocalization thereby
blocking mitochondrial transport [105]. Collectively, the
available evidence strongly points to a co-dependence of
Drp1 and dynein for long-distance mitochondrial traffick-
ing, which is of obvious importance in highly polarized
neurons.
Short-distance mitochondrial transport is mediated by
actin filaments. In analogy to the disruption of dynein
complexes, disruption of actin filaments has been shown to
attenuate mitochondrial Drp1 translocation and organelle
fission [26].
Drp1 in apoptosis
Soon after Drp1’s discovery as a mitochondrial fission
protein, it was observed that the mitochondrial fragmen-
tation occurring during apoptosis could be inhibited by
overexpression of the dominant-negative Drp1 mutant
K38A. Blocking Drp1 function not only inhibited frag-
mentation of the organelles but, more importantly, also
delayed mitochondrial cytochrome c release and sub-
sequent apoptotic cell death [35]. However, the general
necessity of mitochondrial fission for apoptosis to proceed
remains a matter of debate largely attributable to specific
experimental setups (including cell lines, specific stimuli,
differential sensitivity of various cell death detection
assays, as well as different means of Drp1 functional
inactivation) [49, 94, 116].
We would like to restrict our discussion here to com-
ment on the differential results reported for the available
Drp1 knockout mouse models [45, 108]. Whereas Waka-
bayashi et al. [108] using non-immortalized mouse
embryonic fibroblasts in their cell death assays, did not
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observe a delay in apoptosis, the Mihara group using
immortalized fibroblasts were able to show just that [45].
Interestingly, complete Drp1 ablation did not block, yet
delayed mitochondrial fragmentation during apoptosis
[45]. Perhaps, this effect is attributable to compensatory
changes in expression levels of other mitochondria-shaping
proteins, which are already altered at steady state in Drp1
null fibroblasts [45]. In summary, genetic Drp1 ablation
delays programmed cell death but not sufficient to block it.
On the organelle level, Drp1 has been proposed to
facilitate apoptotic cell death by impinging either on outer
mitochondrial membrane permeabilization or, alterna-
tively, on mitochondrial cristae remodeling. Key mediators
of OMM permeabilization are the ‘‘multidomain proap-
optotics’’ Bax and Bak. Both proteins belong to the Bcl-2
family of proteins and get activated in the OMM by so-
called ‘‘BH3-only’’ proteins, a Bcl-2 family subset. Once
activated, mitochondria release proapoptotic factors such
as cytochrome c into the cytosol, where subsequent acti-
vation of downstream effector caspases occurs via
formation of the apoptosome, a specialized protein com-
plex containing APAF1 and pro-caspase-9 [116]. Of note,
in healthy cells, about 85% of the soluble cytochrome
c pool resides within the cristae compartment, made up by
specialized inner mitochondrial membrane structures.
During apoptosis, dramatic morphological changes termed
cristae remodeling take place, facilitating the release of
cytochrome c that takes place during programmed cell
death [7, 93]. Expression of the dominant-negative Drp1
mutant K38A can rescue cristae remodeling induced by
overexpression of the proapoptotic Bcl-2 protein Bik [37]
as well as by expression of mutant huntingtin [21]. As to
now, a plausible answer on how a cytosolic protein such as
Drp1 that anchors to the OMM, can influence cristae
remodeling, is lacking. Indirect effects on the proteolytic
processing of Opa1, a key regulator of cristae morphology,
may represent a plausible scenario as, in fact, levels of
proteolytically derived Opa1 isoforms are altered in several
Drp1-ablated cell models [45, 69].
During apoptosis, Bax translocation from the cytosol to
the OMM is dependent on Drp1 and facilitated by cardi-
olipin, a mitochondrial lipid residing in the IMM. It has
been postulated that, in addition to modulate cristae mod-
eling, Drp1 is involved in the formation of hemifusion sites
that bring inner and outer mitochondrial membranes into
close contact with each other, thereby enabling the
exchange of lipids between the two membranes which
facilitates Bax membrane integration [68]. This mechanism
could be particularly important in neurons, where nitric
oxide donor-induced translocation of Bax to mitochondria
is Drp1 dependent [120]. Of note, the neuronal death in this
model requires Drp1 and Bax but no caspase activation
[120], exemplifying a mode of neuronal damage engaging
certain modules of the molecular apoptosis cascade without
following the complete pathway of classical intrinsic pro-
grammed cell death.
Neuronal apoptosis related to changes in mitochondrial
morphology has poorly been investigated so far. It is
generally difficult to detect in vivo as cells dying by
apoptosis are swiftly removed by microglia [74]. Drp1
knockout neurons, which display an aggregated mito-
chondrial morphology, are more sensitive to the pan-kinase
inhibitor staurosporine (STS) as well as to ceramide, a
Ca2? stress-inducing drug [45].
In contrast, neurons transiently deprived of functional
Drp1 display an elongated mitochondrial phenotype
(Fig. 3b) and show resistance to various apoptotic stimuli
such as STS [21, 66, 119], rotenone [4, 24], MPP? [4],
A-beta peptide 25-35 [4], nitric oxide [4, 120], hydrogen
peroxide [18, 46], and metamphetamine [101] (Fig. 4). The
discrepancy between these conditions of functional Drp1
inactivation with respect to cell death susceptibility may, as
already discussed, be related to the timing of Drp1 abla-
tion: whereas long-term Drp1 ablation favors neuronal
death, short-term deletion seems to exert neuroprotective
effects. The lack of mitochondrial fission under conditions
of genetic Drp1 ablation is likely compensated for by the
degradation of the Opa1 protein along with downregulated
expression of Mfn1 and Mfn2, all of which result in
decreased fusion of the organelles [45]. Interestingly,
in AD brains, Mfn1, Mfn2, Opa1 and Drp1 are simulta-
neously downregulated and this state seems to be
associated with perinuclear mitochondrial aggregation and
decreased numbers of dendrites and synapses [113].
Ca2? influx has already been discussed as an important
inducer of neuronal death. In the context of apoptosis,
increased mitochondrial Ca2? uptake can trigger mito-
chondrial permeability transition, organelle swelling with
rupture of the OMM, culminating in the release of proa-
poptotic factors into the cytosol. In addition, Ca2? activates
calpains which trigger apoptosis by cleavage of the BH3-
only protein Bid and by processing of the Cdk5 activator
p35 to yield the more active p25 form [59]. When activated,
Cdk5, which is highly expressed in postmitotic neurons,
mediates STS-induced caspase-dependent neuronal death
that is preceded by mitochondrial fragmentation [66]. In
summary, for neurons, currently available evidence sug-
gests a tight interplay between pathways of Ca2?-mediated
neuronal death and classical apoptosis that in both cases
involves dysregulated mitochondrial dynamics (Fig. 4).
Therapeutic targeting of mitochondria
Most avenues for therapeutic targeting of mitochondria
have so far been focused on counteracting ROS production
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by directing antioxidant molecules to the organelles [20].
For some CNS pathologies with underlying defects in
mitochondrial function or energy production, such as
ischemia, creatine, which is already approved for the
adjuvant treatment of various myopathies, may be a
promising candidate. Creatine has long been shown to
increase mitochondrial respiration [110] and to promote
neurite formation in vitro [56]. Furthermore, in rodent
models of brain ischemia, creatine administration reduces
infarct volumes [85]. In addition to this more ‘‘traditional’’
approach, tinkering chemically with the mitochondrial
fusion/fission machinery seems to have great therapeutic
potential through modulating organelle function. As dis-
cussed, genetic Drp1 ablation during neuronal development
dramatically blocks synapse and neurite formation [45, 56]
and Drp1 ablation in differentiated cultured neurons can
even lead to cell death [104]. On the other hand, mito-
chondrial fission, mediated by Drp1, favors neuronal
apoptosis [68] and toxin-mediated neuronal death [4, 21,
24, 66, 101, 119, 120] while inhibiting the formation of
protective, metabolically more efficient hyperfused mito-
chondrial networks [38]. Hence, transient blockage of
organelle fission during acute situations such as ischemic
stroke may represent a veritable strategy to counteract
neuronal damage. In addition, pharmacological modulation
of mitochondrial fission in Huntington’s disease where
neurodegenerative pathology seems to directly result from
imbalanced mitochondrial fusion and fission events, might
represent another plausible therapeutic strategy. So far, all
known small molecule compounds that modify mitochon-
drial morphology impinge on Drp1 either directly as is the
case for mdivi-1 [12], or indirectly via inhibition of cal-
cineurin, which can be achieved by FK506 (already FDA
approved as immunosuppressant) or by PPD1 [13, 14].
Significantly, mdivi-1 has already proven its efficacy in
several rodent ischemia models [10, 12, 77, 82], whereas
FK506 has only recently shown in vitro efficacy in pro-
tecting murine huntingtin knockin neurons from mild
apoptotic stimuli [88].
Targeting of calpains and Cdk5 represents an effective
strategy to inhibit Ca2?-mediated neuronal death upstream
of mitochondrial fragmentation. A variety of calpain
inhibitors have already proven to be protective in animal
stroke models. However, non-selective calpain isoform
inhibition has so far hampered respective clinical trials
[29]. (S)-roscovitine, a novel Cdk5 inhibitor, has recently
been tested successfully in a mouse stroke model, where it
significantly reduced ischemic infarct size [64].
In summary, targeting mitochondria, either via modu-
lating the balance between mitochondrial fission and fusion
events or by interfering with Ca2?-induced cell death
pathways, represents a novel strategy to counteract neu-
ronal cell death. Especially, in acute situations such as
ischemic stroke, modulating mitochondrial dynamics by
inhibition of Drp1-driven mitochondrial fragmentation
seems to be a promising therapeutic approach.
Summary and perspective
Since the concept of dysregulated mitochondrial dynamics
has been introduced to the readers of Acta Neuropathol-
ogica in 2006 [34], we have seen a tremendous extension of
our knowledge on the molecular mechanisms underlying
mitochondrial fission and fusion processes. Moreover, it is
now generally accepted that the dysregulation of mito-
chondrial dynamics is either causative or at least a
significant factor in the pathogenesis of a spectrum of
human disorders such as stroke, obesity, diabetes mellitus
as well as neurodegenerative diseases. A detailed under-
standing of how dysregulated mitochondrial morphology
leads to neuronal damage is a prerequisite to successfully
interfere with mitochondria-driven neurodegenerative
pathways. The recent development of small molecule
inhibitors capable of counteracting inappropriately acti-
vated mitochondrial fission may represent a promising
neuroprotective strategy.
Fig. 4 Mitochondrial fission in neuronal death. Mitochondrial fission
has been implicated in the pathogenesis of several neurodegenerative
diseases. Compounds mimicking neurotoxicity as it occurs in
neurodegeneration have in vitro been shown to mediate neuronal
death dependent on mitochondrial fission. Interestingly, Cdk5,
implicated in the pathogenesis of several neurodegenerative condi-
tions, functions as an upstream regulator of mitochondrial fission
during neuronal apoptosis. The protein also plays a prominent role in
Ca2?-mediated cell death pathways. Here, Ca2?-activated calpains
process the p35 Cdk5 activator protein to yield p25, resulting in
enhanced Cdk5 activity. In addition, Ca2? can also directly trigger
mitochondrial fragmentation by calcineurin-mediated Drp1 S637. On
the organelle level, intramitochondrial Ca2? accumulation may lead
to organelle swelling, opening of the permeability transition pore, and
OMM rupture, culminating in the release of proapoptotic factors such
as cytochrome c from the mitochondria into the cytosol
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